Title:
Endoperoxides as Antimalarials: Development, Structural Diversity, and Pharmacodynamic Aspects of 1,2,4,5-Tetraoxane-Based Structural Scaffolds

dc.contributor.authorUpendra Kumar Patel
dc.contributor.authorAlka Alka
dc.contributor.authorAlka K. Agarwal
dc.date.accessioned2026-02-19T13:25:24Z
dc.date.issued2025
dc.description.abstractMalaria poses a serious threat to human life and is prevalent in tropical and subtropical areas across the globe. Drugs such as quinine, chloroquine (a synthetic version of quinine), artemisinin, and its derivative compounds have been used to treat malaria. Developing highly effective chemical scaffolds with minimal toxicity is necessary because malarial parasites have become resistant to existing drugs. In this context, 1,2,4,5-tetraoxanes have emerged as a crucial framework with notable antimalarial properties. To improve the effectiveness and combat resistance to various antimalarial drugs, 1,2,4,5-tetraoxanes have been combined with a variety of alicyclic, aryl, heteroaryl, and spiro groups including steroid-based, aminoquinoline-based, dispiro-based, triazine-based, diaryl-based, and piperidine-based 1,2,4,5-tetraoxanes. We provide an overview of the synthesis and most important in vitro and in vivo investigations carried out on hybrids based on 1,2,4,5-tetraoxane as antimalarial drugs. The future development of malaria treatment may be influenced by the structural changes in different hybrids of 1,2,4,5-tetraoxane. 1 Introduction 2 Synthetic Methods for Tetraoxanes 3 Antimalarial Activities of Tetraoxane Derivatives 3.1 Cycloalkanone-Based Tetraoxanes 3.2 Steroid-Based Tetraoxanes 3.3 Adamantane-Based Tetraoxanes 3.4 Dispiro-Based Tetraoxanes 3.5 Diaryl-Based Tetraoxanes 3.6 Di-adamantane-Based Tetraoxanes 3.7 Benzylamino- and Aryloxy-Based Tetraoxanes 3.8 Aminoquinoline-Based Tetraoxanes 3.9 2-Cyanopyrimidine-Based Tetraoxanes 4 Mannich Base Based Tetraoxanes 4.1 N -Sulfonylpiperidine-Based Tetraoxanes 4.2 N -Benzoylpiperidine-Based Tetraoxanes 5 Mechanism of Action of Dispiro-1,2,4,5-tetraoxanes 6 Conclusion. © 2025. The Author(s). SynOpen.
dc.identifier.doi10.1055/s-0043-1775432
dc.identifier.urihttps://doi.org/10.1055/s-0043-1775432
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/64838
dc.publisherGeorg Thieme Verlag
dc.subject1,2,4,5-tetraoxane
dc.subject1,2,4,5-tetroxane
dc.subjectartemisinin
dc.subjectcentral nervous system (CNS)
dc.subjectcerebral malaria
dc.subjectendoperoxide
dc.subjectsesquiterpene
dc.titleEndoperoxides as Antimalarials: Development, Structural Diversity, and Pharmacodynamic Aspects of 1,2,4,5-Tetraoxane-Based Structural Scaffolds
dc.typePublication
dspace.entity.typeReview

Files

Collections